Nalfurafine hydrochloride: A new drug for the treatment of uremic pruritus in hemodialysis patients

Drugs of Today

Volumn 45, Issue 5, 2009, Pages 323-329

  Nakao, Kaoru ^a   Mochizuki, Hidenori ^a  

^a TORAY INDUSTRIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPRURITIC AGENT; BUPRENORPHINE; BUTORPHANOL; CHLORPHENIRAMINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FORSKOLIN; HISTAMINE; KAPPA OPIATE RECEPTOR; KETOTIFEN; MORPHINE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALFURAFINE; NEW DRUG; NORBINALTORPHIMINE; SUBSTANCE P;

BINDING AFFINITY; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; HEADACHE; HEMODIALYSIS PATIENT; HUMAN; INSOMNIA; NAUSEA AND VOMITING; NONHUMAN; PATHOPHYSIOLOGY; PRURITUS; REVIEW; UREMIA; UREMIC PRURITUS; VERTIGO;

ANIMALS; HUMANS; MORPHINANS; PRURITUS; RECEPTORS, OPIOID, KAPPA; RENAL DIALYSIS; SPIRO COMPOUNDS; UREMIA;

EID: 69249192713     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2009.45.5.1377595     Document Type: Review

References (34)

1. Pisoni, R.L., Wikström, B., Elder, S.J. et al. Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006, 21(12): 3495-3505 (Pubitemid 44817100)
2. Patel, T.S., Freedman, B.I., Yosipovitch, G. An update on pruritus associated with CKD. Am J Kidney Dis 2007, 50(1): 11-20. (Pubitemid 46964882)
3. Massry, S.G., Popovtzer, M.M., Coburn, J.W., Makoff, D.L., Maxwell, M.H., Kleeman, C.R. Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy. N Engl J Med 1968, 279(13): 697-700.
4. Johansson, O., Hilliges, M., Ståhle-Bäckdahl, M. Intra-epidermal neuron-specific enolase (NSE)-immunoreactive nerve fibres: Evidence for sprouting in uremic patients on maintenance haemodialysis. Neurosci Lett 1989, 99(3): 281-6. (Pubitemid 19108767)
5. Kimmel, M., Alscher, D.M., Dunst, R. et al. The role of microinflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant 2006, 21(3): 749-755 (Pubitemid 43378900)
6. Stockenhuber, F., Kurz, R.W., Sertl, K., Grimm, G., Balcke, P. Increased plasma histamine levels in uraemic pruritus. Clin Sci (Lond) 1990, 79(5): 477-482
7. Kaku, H., Fujita, Y., Yago, H. et al. S. Study on pruritus in hemodialysis patients and the antipruritic effect of neurotropin: Plasma levels of substance P, somatostatin, IgE, PTH and histamine. Nippon Jinzo Gakkai Shi 1990, 32(3): 319-326
8. Thornton, J.R., Losowsky, M.S. Plasma β endorphin in cirrhosis and renal failure. Gut 1991, 32(3): 306-308
9. Danno, K., Nishiura, K., Tanaka, M. Increased metenkephalin plasma levels in hemodialysis patients with or without pruritus. J Dermatol Sci 1995, 10(3): 238-240
10. Kumagai, H., Saruta, T., Matsukawa, S., Utsumi, J. Prospects for a novel κ-opioid receptor agonist, TRK-820, in uremic pruritus. In: Itch. Basic Mechanisms and Therapy. G. Yosipovitch, M.W. Greaves, A.B. Fleischer Jr., F. McGlone (Eds). Marcel Dekker Inc.: New York 2004, 279-286
11. Peer, G., Kivity, S., Agami, O., Fireman, E., Silverberg, D., Blum, M., Iaina, A. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 1996, 348(9041): 1552-1554 (Pubitemid 26411654)
12. Pauli-Magnus, C., Mikus, G., Alscher D.M. et al. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol 2000, 11(3): 514-519 (Pubitemid 30115081)
13. Pan, Z.Z. μ-Opposing actions of the κ-opioid receptor. Trends Pharmacol Sci 1998, 19(3): 94-98
14. Nagase, H., Hayakawa, J., Kawamura, K., Kawai, K., Takezawa, Y., Matsuura, H., Tajima, C., Endo, T. Discovery of a structurally novel opioid κ-agonist derived from 4,5-epoxymorphinan. Chem Pharm Bull (Tokyo) 1998, 46(2): 366-369 (Pubitemid 28124231)
15. Seki, T., Awamura, S., Kimura, C., Ide, S., Sakano, K., Minami, M., Nagase, H., Satoh, M. Pharmacological properties of TRK-820 on cloned μ-, δ- and κ-opioid receptors and nociceptin receptor. Eur J Pharmacol 1999, 376(1-2): 159-167 (Pubitemid 29320181)
16. Nakao, K., Ikeda, K., Kurokawa, T., Togashi, Y., Umeuchi, H., Honda, T., Okano, K., Mochizuki, H. Effect of TRK-820, a selective κ opioid receptor agonist, on scratching behavior in an animal model of atopic dermatitis. Nihon Shinkei Seishin Yakurigaku Zasshi 2008, 28(2): 75-83.
17. Hägermark, Ö., Hökfelt, T., Pernow, B. Flare and itch induced by substance P in human skin. J Invest Dermatol 1978, 71(4): 233-235 (Pubitemid 9094481)
18. Fjellner, B., Hägermark, Ö. Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters. Acta Derm Venereol 1981, 61(3): 245-250 (Pubitemid 11107483)
19. Cousins, M.J., Mather, L.E. Intrathecal and epidural administration of opioids. Anesthesiology 1984, 61(3): 276-310.
20. Ballantyne, J.C., Loach, A.B., Carr, D.B. Itching after epidural and spinal opiates. Pain 1988, 33(2): 149-160
21. Kuraishi, Y., Nagasawa, T., Hayashi, K., Satoh, M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur J Pharmacol 1995, 275(3): 229-233
22. Andoh, T., Nagasawa, T., Satoh, M., Kuraishi, Y. Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice. J Pharmacol Exp Ther 1998, 286(3): 1140-1145 (Pubitemid 29135521)
23. Tohda, C., Yamaguchi, T., Kuraishi, Y. Intracisternal injection of opioids induces itch-associated response through μ-opioid receptors in mice. Jpn J Pharmacol 1997, 74(1): 77-82. (Pubitemid 27254700)
24. Togashi, Y., Umeuchi, H., Okano, K. et al. Antipruritic activity of the κ-opioid receptor agonist, TRK-820. Eur J Pharmacol 2002, 435(2-3): 259-264 (Pubitemid 34131709)
25. Umeuchi, H., Togashi, Y., Honda, T., Nakao, K., Okano, K., Tanaka, T., Nagase, H. Involvement of central μ-opioid system in the scratching behavior in mice, and the suppression of it by the activation of κ-opioid system. Eur J Pharmacol 2003, 477(1): 29-35. (Pubitemid 38366082)
26. Wakasa, Y., Fujiwara, A., Umeuchi, H., Endoh, T., Okano, K., Tanaka, T., Nagase, H. Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys. Life Sci 2004, 75(24): 2947-2957 (Pubitemid 39349259)
27. Ko, M.C., Husbands, S.M. Effects of atypical κ-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates. J Pharmacol Exp Ther 2009, 328(1): 193-200.
28. Tarng, D.C., Cho, Y.L., Liu, H.N., Huang, T.P. Hemodialysis-related pruritus: A double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream. Nephron 1996, 72(4): 617-622
29. Umeuchi, H., Kawashima, Y., Aoki, C.A. et al. Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel κ-opioid receptor agonist nalfurafine hydrochloride. Eur J Pharmacol 2005, 518(2-3): 133-139 (Pubitemid 41133636)
30. Inan, S., Cowan, A. Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats. Pharmacol Biochem Behav 2006, 85(1): 39-43. (Pubitemid 44772907)
31. Darsow, U., Scharein, E., Bromm, B., Ring, J. Skin testing of the pruritogenic activity of histamine and cytokines (interleukin-2 and tumour necrosis factor-α) at the dermal-epidermal junction. Br J Dermatol 1997, 137(3): 415-417 (Pubitemid 27421571)
32. Woodward, D.F., Nieves, A.L., Friedlaender, M.H. Characterization of receptor subtypes involved in prostanoid-induced conjunctival pruritus and their role in mediating allergic conjunctival itching. J Pharmacol Exp Ther 1996, 279(1): 137-142
33. Andoh, T., Kuraishi, Y. Nitric oxide enhances substance P-induced itch-associated responses in mice. Br J Pharmacol 2003, 138(1): 202-208 (Pubitemid 36194221)
34. Wikström, B., Gellert, R., Ladefoged, S.D. et al. κ-Opioid system in uremic pruritus: Multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol 2005, 16(12): 3742-3747 (Pubitemid 46211297)